2.26 score from hupso.pl for:
aidsmap.com



HTML Content


Title hiv & aids information :: home

Length: 39, Words: 5
Description nam and aidsmap work to change lives by sharing information about hiv and aids. we believe independent, clear and accurate information is vital in the fight against hiv and aids

Length: 177, Words: 30
Keywords pusty
Robots
Charset UTF-8
Og Meta - Title exist
Og Meta - Description exist
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 3112
Text/HTML 22.63 %
Headings H1 1
H2 1
H3 16
H4 7
H5 14
H6 3
H1
home
H2
start here – hiv factsheets
H3
start here – hiv factsheets
nam is official hr17 scientific reporter
new prep trial for 2017
antiretroviral drugs chart
new website: about hiv / pro vich
sign up
recently diagnosed
clinic portal
find an hiv service
connect with nam
aidsmap hiv & aids news
editor's picks from other sources
e-atlas mozambique
a to z of topics
a to z of drugs
nam blog
H4 people taking art in the uk have an accurate understanding of their viral load
implants and injectables: prep in the future
risk of pregnancy loss among smokers much higher for women with hiv
risk score accurately predicts which pregnant and postpartum women would benefit most from prep
nearly two-thirds of european hiv cases are now in russia
scaling up adult male circumcision calculated to have hiv prevention benefits additional to those seen with 90-90-90 treatment target
viral load rebounds in a third of women who start hiv therapy during pregnancy or postpartum, south african study shows
H5 converging roads between hiv and cancer research
zimbabwe: zim to roll out pre-exposure hiv pill
guide to prosecuting hiv cases ‘undermining’ public health, critics say
criminalization of hiv non-disclosure a bigger burden on women, advocates say
hiv diagnoses falling steeply, early figures show: london clinics see hope in increased use of pre-exposure prophylaxis
why addicts take drugs in 'fix rooms'
worried about hiv and aging? the first thing to do is stop smoking
european commission grants marketing authorization for gilead’s vemlidy® (tenofovir alafenamide, taf) for the treatment of chronic hepatitis b virus infection
bacterial communities of female genital tract impact hiv infection risk
london doctors on verge of defeating hiv thanks to new programme
knights of malta condom scandal stretches from myanmar to the vatican
fighting trump: hiv advocates to watch in 2017
find news, resources and services from mozambique
or select a country from the list below
H6 more
aidsmap news feeds
email updates
strong
nam publications
b
i
nam publications
em
Bolds strong 1
b 0
i 1
em 0
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 20
Pliki CSS 10
Pliki javascript 10
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 480
Linki wewnętrzne 460
Linki zewnętrzne 20
Linki bez atrybutu Title 480
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

home /
news /news
latest news /latest-news
people taking art in the uk have an accurate understanding of their viral load /art-treated-patients-in-uk-have-an-accurate-understanding-of-their-viral-load/page/3111214/
implants and injectables: prep in the future /implants-and-injectables-prep-in-the-future/page/3110737/
risk of pregnancy loss among smokers much higher for women with hiv /risk-of-pregnancy-loss-among-smokers-much-higher-for-women-with-hiv/page/3109946/
features /latest-news#featureslist
new $90-$90-$90 target needed for global viral hepatitis, hiv and tb treatment /new-90-90-90-target-needed-for-global-viral-hepatitis-hiv-and-tb-treatment/page/3101194/
rings, films or inserts? researchers need to develop prevention products that make sense in women’s lives /rings-films-or-inserts-researchers-need-to-develop-prevention-products-that-make-sense-in-womens-lives/page/3101193/
policy makers' inaction is leading people to take prep 'in the wild' /policy-makers-inaction-is-leading-people-to-take-prep-in-the-wild/page/3093976/
media reports of a british hiv cure 'breakthrough' are premature /media-reports-of-a-british-hiv-cure-breakthrough-are-premature/page/3087975/
easl issues new hepatitis c treatment recommendations for all genotypes /easl-issues-new-hepatitis-c-treatment-recommendations-for-all-genotypes/page/3088069/
news by topic /news/news-by-topic/page/1404239/
hiv update /hiv-update
news feeds /news/news-feeds/page/1444172/
conference news /conferences
hiv basics /hiv-basics
hiv & aids /hiv-basics/hiv-aids/page/1412437/
transmission /hiv-basics/transmission/page/1412438/
testing /hiv-basics/testing/page/1412439/
treatment /hiv-basics/treatment/page/1412440/
just diagnosed /hiv-basics/just-diagnosed/page/1412441/
looking for support in your area? /hiv-basics/looking-for-support-in-your-area/page/1412442/
topics /topics
testing and health monitoring /testing-and-health-monitoring/cat/1379/
hiv testing /hiv-testing/cat/1471/
health monitoring /health-monitoring/cat/1655/
hiv treatment /hiv-treatment/cat/1378/
treatment guidelines /treatment-guidelines/cat/1469/
starting treatment /starting-treatment/cat/1670/
side-effects /side-effects/cat/1463/
adherence /adherence/cat/1464/
drug interactions and pharmacokinetics /drug-interactions-and-pharmacokinetics/cat/1465/
treatment for women /treatment-for-women/cat/1467/
resistance /resistance/cat/1461/
changing treatment /changing-treatment/cat/1462/
treatment interruptions /treatment-interruptions/cat/1466/
treatment-experienced people /treatment-experienced-people/cat/1671/
new and experimental hiv treatments /new-and-experimental-hiv-treatments/cat/1673/
outcomes and prognosis /outcomes-and-prognosis/cat/1733/
the search for a cure /the-search-for-a-cure/cat/80321/
bad science and bogus treatments /bad-science-and-bogus-treatments/cat/80329/
transmission and prevention /transmission-and-prevention/cat/1377/
infectiousness and treatment as prevention /infectiousness-and-treatment-as-prevention/cat/1624/
prep /prep/cat/1623/
how transmission occurs /how-transmission-occurs/cat/1613/
sexual transmission /sexual-transmission/cat/1614/
medical procedures and other blood-borne exposure /medical-procedures-and-other-blood-borne-exposure/cat/1617/
low and theoretical transmission risks /low-and-theoretical-transmission-risks/cat/1618/
condoms and lubricant /condoms-and-lubricant/cat/1621/
harm reduction /harm-reduction/cat/81851/
circumcision /circumcision/cat/1622/
pep /pep/cat/1455/
behaviour change interventions /behaviour-change-interventions/cat/1620/
microbicides /microbicides/cat/1453/
vaccines /vaccines/cat/1459/
spermwashing /spermwashing/cat/1626/
epidemiology and behaviour /epidemiology-and-behaviour/cat/1734/
hiv prevention policy /hiv-prevention-policy/cat/80322/
structural factors /structural-factors/cat/80815/
social and legal issues /social-and-legal-issues/cat/1525/
telling people you have hiv /telling-people-you-have-hiv/cat/1537/
finding support /finding-support/cat/1535/
hiv and criminal law /hiv-and-criminal-law/cat/1686/
drug policy and policing /drug-policy-and-policing/cat/82203/
immigration /immigration/cat/1527/
money, benefits and housing /money-benefits-and-housing/cat/1529/
employment /employment/cat/1684/
religion and faith /religion-and-faith/cat/1644/
confidentiality, consent and medical ethics /confidentiality-consent-and-medical-ethics/cat/1687/
travel /travel/cat/1688/
end-of-life issues /end-of-life-issues/cat/1530/
experiences of stigma /experiences-of-stigma/cat/80323/
discrimination and the law /discrimination-and-the-law/cat/80324/
human rights /human-rights/cat/80325/
combatting stigma /combatting-stigma/cat/80326/
history of hiv and aids /history-of-hiv-and-aids/cat/80327/
people and personal stories /people-and-personal-stories/cat/82754/
hepatitis and hiv /hepatitis-and-hiv/cat/1508/
hepatitis c /hepatitis-c/cat/1509/
hepatitis b /hepatitis-b/cat/1510/
hepatitis a /hepatitis-a/cat/1627/
families and children /families-and-children/cat/1482/
prevention of mother-to-child transmission /prevention-of-mother-to-child-transmission/cat/1483/
hiv treatment in children /hiv-treatment-in-children/cat/1661/
infant feeding /infant-feeding/cat/1718/
conception /conception/cat/1488/
disclosure and children /disclosure-and-children/cat/1484/
diagnosing children /diagnosing-children/cat/1485/
hiv in children /hiv-in-children/cat/1660/
child developmental issues /child-developmental-issues/cat/1487/
support for families and children /support-for-families-and-children/cat/1662/
reproductive health /reproductive-health/cat/80812/
tuberculosis and hiv /tuberculosis-and-hiv/cat/1502/
tb vaccine /tb-vaccine/cat/1666/
tb transmission /tb-transmission/cat/1667/
tb prevention /tb-prevention/cat/1668/
tb symptoms /tb-symptoms/cat/1669/
tb diagnosis /tb-diagnosis/cat/1504/
tb treatment /tb-treatment/cat/1506/
drug-resistant tb /drug-resistant-tb/cat/1503/
tb services /tb-services/cat/1505/
hiv and sex /hiv-and-sex/cat/1540/
safer sex /safer-sex/cat/1546/
relationships and feelings /relationships-and-feelings/cat/1663/
contraception /contraception/cat/1544/
sexually transmitted infections /sexually-transmitted-infections/cat/1542/
health services and systems /health-services-and-systems/cat/1513/
delivery of care /delivery-of-care/cat/1519/
task shifting /task-shifting/cat/1717/
uk health services /uk-health-services/cat/1680/
palliative care /palliative-care/cat/1715/
epidemiology /epidemiology/cat/1682/
clinical trials /clinical-trials/cat/1683/
policy /policy/cat/1716/
activism /activism/cat/1645/
pharmaceutical industry /pharmaceutical-industry/cat/1646/
finance and funding /finance-and-funding/cat/1651/
global health initiatives /global-health-initiatives/cat/1650/
access to medicines and treatment /access-to-medicines-and-treatment/cat/80320/
retention and linkage to care /retention-and-linkage-to-care/cat/80814/
achieving the 90-90-90 target /achieving-the-90-90-90-target/cat/82765/
health problems /health-problems/cat/1489/
kidney problems /kidney-problems/cat/1723/
ageing and hiv /ageing-and-hiv/cat/1985/
mental and emotional health /mental-and-emotional-health/cat/1500/
opportunistic infections /opportunistic-infections/cat/1495/
cancer /cancer/cat/1679/
cardiovascular disease /cardiovascular-disease/cat/1493/
diabetes /diabetes/cat/1494/
malaria /malaria/cat/1499/
neurological and cognitive problems /neurological-and-cognitive-problems/cat/1719/
bone problems /bone-problems/cat/1724/
lipodystrophy /lipodystrophy/cat/1616/
malnutrition /malnutrition/cat/1642/
how hiv works /how-hiv-works/cat/1440/
what is hiv? /what-is-hiv/cat/1444/
what is aids? /what-is-aids/cat/1443/
how hiv causes disease /how-hiv-causes-disease/cat/1445/
healthy living /healthy-living/cat/1380/
mental and emotional health /mental-and-emotional-health/cat/1476/
nutrition /nutrition/cat/1480/
exercise /exercise/cat/1478/
recreational drug use /recreational-drug-use/cat/1477/
alcohol /alcohol/cat/1674/
smoking /smoking/cat/1481/
complementary therapies /complementary-therapies/cat/1675/
immunisations /immunisations/cat/1676/
sleep /sleep/cat/1677/
living well with a low cd4 count /living-well-with-a-low-cd4-count/cat/1678/
view full list of topics /topics
resources /resources
featured resources /resources
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
your next steps /your-next-steps/page/1412486/
view a full list of nam's resources /resources
the basics /thebasics
booklets /booklets
apps and online tools /apps
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
translations /translations
arabic /arabic
armenian /translations/armenian/page/3097762/
dutch (nederlands) /dutch
finnish (suomen kieli) /finnish
french (français) /fr
georgian /translations/georgian/page/3097990/
german (deutsch) /german
hebrew /hebrew
italian (italiano) /italian
kazakh (қазақ) /translations/kazakh/page/3098009/
norwegian (norsk) /norwegian
polish (polski) /polish
portuguese (português) /pt
romanian (română) /ro
russian (русский) /ru
somali /translations/somali/page/1563375/
spanish (español) /es
swedish (svenska) /swedish
thai /thai
turkish (türk) /turkish
ukrainian (yкраїнський) /translations/ukrainian-y/page/3097656/
translating our resources /translations/translating-our-resources/page/1443865/
e-atlas /e-atlas
search for hiv services across the world /e-atlas
get country-specific news and resources /e-atlas/country/
search for hiv services in the uk /e-atlas/uk/
about us /aboutus
nam blog /nam-blog
nam is the official scientific reporter for the 25th international harm reduction conference (hr17) /nam-is-the-official-scientific-reporter-for-the-25th-international-harm-reduction-conference-hr17/page/3108875/
start here – our factsheets on hiv prevention and treatment /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
world aids day /world-aids-day/page/3101205/
who we are /aboutus/who-we-are/page/1276062/
what we do /aboutus/what-we-do/page/1277746/
maintaining high standards /aboutus/maintaining-high-standards/page/1439294/
how you can support us /aboutus/how-you-can-support-us/page/1439295/
how your support makes a difference /aboutus/how-your-support-makes-a-difference/page/1439296/
confidentiality /aboutus/confidentiality/page/1439297/
using nam’s resources /aboutus/using-nams-resources/page/1439298/
contact us /contact
donate /donate
more about us > /aboutus
- /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
start here – hiv factsheets /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
visit our factsheets page /factsheets
find out more in our blog /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
- /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
start here – hiv factsheets /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
visit our factsheets page /factsheets
find out more in our blog /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
- /nam-is-the-official-scientific-reporter-for-the-25th-international-harm-reduction-conference-hr17/page/3108875/
nam is official hr17 scientific reporter /nam-is-the-official-scientific-reporter-for-the-25th-international-harm-reduction-conference-hr17/page/3108875/
find out more in our blog /nam-is-the-official-scientific-reporter-for-the-25th-international-harm-reduction-conference-hr17/page/3108875/
sign up to receive the conference bulletin /hr17
- /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
new prep trial for 2017 /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
read more about the trial in our news story /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
read how to get prep in the uk /how-to-get-prep-in-the-uk/page/3089865/
read pre-exposure prophylaxis (prep) /pre-exposure-prophylaxis-prep/page/2989437/
- /resources/antiretroviral-drugs-chart/page/1412453/
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
view the drugs chart online /resources/antiretroviral-drugs-chart/page/1412453/
- /launch-of-about-hiv-pro-vich-website/page/3093196/
new website: about hiv / pro vich /launch-of-about-hiv-pro-vich-website/page/3093196/
find out more on the nam blog /launch-of-about-hiv-pro-vich-website/page/3093196/
sign up /bulletins
recently diagnosed /hiv-basics/just-diagnosed/page/1412441/
find an hiv service /e-atlas
connect with nam /aboutus/contact/social-media/page/1563489/
people taking art in the uk have an accurate understanding of their viral load /art-treated-patients-in-uk-have-an-accurate-understanding-of-their-viral-load/page/3111214/
viral load /news/news-by-topic/viral-load/cat/1657/page/1404239/
... /art-treated-patients-in-uk-have-an-accurate-understanding-of-their-viral-load/page/3111214/
implants and injectables: prep in the future /implants-and-injectables-prep-in-the-future/page/3110737/
prep /news/news-by-topic/prep/cat/1623/page/1404239/
... /implants-and-injectables-prep-in-the-future/page/3110737/
risk of pregnancy loss among smokers much higher for women with hiv /risk-of-pregnancy-loss-among-smokers-much-higher-for-women-with-hiv/page/3109946/
smoking /news/news-by-topic/smoking/cat/1481/page/1404239/
... /risk-of-pregnancy-loss-among-smokers-much-higher-for-women-with-hiv/page/3109946/
risk score accurately predicts which pregnant and postpartum women would benefit most from prep /risk-score-accurately-predicts-which-pregnant-and-postpartum-women-would-benefit-most-from-prep/page/3109960/
prep /news/news-by-topic/prep/cat/1623/page/1404239/
... /risk-score-accurately-predicts-which-pregnant-and-postpartum-women-would-benefit-most-from-prep/page/3109960/
nearly two-thirds of european hiv cases are now in russia /nearly-two-thirds-of-european-hiv-cases-are-now-in-russia/page/3109895/
epidemiology /news/news-by-topic/epidemiology/cat/1682/page/1404239/
... /nearly-two-thirds-of-european-hiv-cases-are-now-in-russia/page/3109895/
scaling up adult male circumcision calculated to have hiv prevention benefits additional to those seen with 90-90-90 treatment target /scaling-up-adult-male-circumcision-calculated-to-have-hiv-prevention-benefits-additional-to-those-seen-with-90-90-90-treatment-target/page/3104555/
circumcision /news/news-by-topic/circumcision/cat/1622/page/1404239/
... /scaling-up-adult-male-circumcision-calculated-to-have-hiv-prevention-benefits-additional-to-those-seen-with-90-90-90-treatment-target/page/3104555/
viral load rebounds in a third of women who start hiv therapy during pregnancy or postpartum, south african study shows /viral-load-rebounds-in-a-third-of-women-who-start-hiv-therapy-during-pregnancy-or-postpartum-south-african-study-shows/page/3107706/
prevention of mother-to-child transmission /news/news-by-topic/prevention-of-mother-to-child-transmission/cat/1483/page/1404239/
... /viral-load-rebounds-in-a-third-of-women-who-start-hiv-therapy-during-pregnancy-or-postpartum-south-african-study-shows/page/3107706/
more news from aidsmap /latest-news
converging roads between hiv and cancer research /aggregator.ashx?url=http%3a%2f%2fwww.iasociety.org%2fthe-latest%2fblog%2farticleid%2f123%2fconverging-roads-between-hiv-and-cancer-research
zimbabwe: zim to roll out pre-exposure hiv pill /aggregator.ashx?url=http%3a%2f%2fallafrica.com%2fstories%2f201612190138.html
guide to prosecuting hiv cases ‘undermining’ public health, critics say /aggregator.ashx?url=https%3a%2f%2fwww.thestar.com%2fnews%2fgta%2f2017%2f01%2f15%2fguide-to-prosecuting-hiv-cases-undermining-public-health-critics-say.html
criminalization of hiv non-disclosure a bigger burden on women, advocates say /aggregator.ashx?url=https%3a%2f%2fwww.thestar.com%2fnews%2fcanada%2f2017%2f01%2f15%2fcriminalization-of-hiv-non-disclosure-a-bigger-burden-on-women-advocates-say.html
hiv diagnoses falling steeply, early figures show: london clinics see hope in increased use of pre-exposure prophylaxis /aggregator.ashx?url=https%3a%2f%2fwww.ft.com%2fcontent%2f0f63d080-d8bc-11e6-944b-e7eb37a6aa8e
why addicts take drugs in 'fix rooms' /aggregator.ashx?url=http%3a%2f%2fwww.bbc.co.uk%2fnews%2fmagazine-38531307
worried about hiv and aging? the first thing to do is stop smoking /aggregator.ashx?url=http%3a%2f%2fwww.thebody.com%2fcontent%2f79159%2fworried-about-hiv-and-aging-the-first-thing-to-do-.html
european commission grants marketing authorization for gilead’s vemlidy® (tenofovir alafenamide, taf) for the treatment of chronic hepatitis b virus infection /aggregator.ashx?url=http%3a%2f%2fwww.gilead.com%2fnews%2fpress-releases%2f2017%2f1%2feuropean-commission-grants-marketing-authorization-for-gileads-vemlidy-tenofovir-alafenamide-taf-for-the-treatment-of-chronic-hepatitis-b-virus-infection
bacterial communities of female genital tract impact hiv infection risk /aggregator.ashx?url=http%3a%2f%2fwww.ragoninstitute.org%2fbacterial-communities-of-female-genital-tract-impact-hiv-infection-risk%2f
london doctors on verge of defeating hiv thanks to new programme /aggregator.ashx?url=http%3a%2f%2fwww.standard.co.uk%2fnews%2fhealth%2flondon-doctors-on-verge-of-defeating-hiv-thanks-to-new-programme-a3437851.html
knights of malta condom scandal stretches from myanmar to the vatican /aggregator.ashx?url=https%3a%2f%2fwww.theguardian.com%2fworld%2f2017%2fjan%2f11%2fknights-of-malta-condom-scandal-stretches-from-myanmar-to-the-vatican
fighting trump: hiv advocates to watch in 2017 /aggregator.ashx?url=http%3a%2f%2fmarksking.com%2fmy-fabulous-disease%2ffighting-trump-hiv-advocates-to-watch-in-2017%2f
more editor's picks /latest-news
mozambique /mozambique/cat/1364/
- /mozambique/cat/1364/
6 services /hiv-aids-services/mozambique/cat/1364/page/1871278/
91 news articles /news-and-statistics/mozambique/cat/1364/page/1332400/
58 editors' picks /news-and-statistics/mozambique/cat/1364/page/1332400/
access to medicines and treatment /access-to-medicines-and-treatment/cat/80320/
achieving the 90-90-90 target /achieving-the-90-90-90-target/cat/82765/
activism /activism/cat/1645/
adherence /adherence/cat/1464/
africans in the uk /africans-in-the-uk/cat/1732/
ageing and hiv /ageing-and-hiv/cat/1985/
alcohol /alcohol/cat/1674/
bad science and bogus treatments /bad-science-and-bogus-treatments/cat/80329/
behaviour change interventions /behaviour-change-interventions/cat/1620/
bone problems /bone-problems/cat/1724/
cancer /cancer/cat/1679/
cardiovascular disease /cardiovascular-disease/cat/1493/
cd4 count /cd4-count/cat/1656/
changing treatment /changing-treatment/cat/1462/
child developmental issues /child-developmental-issues/cat/1487/
circumcision /circumcision/cat/1622/
clinical trials /clinical-trials/cat/1683/
combatting stigma /combatting-stigma/cat/80326/
complementary therapies /complementary-therapies/cat/1675/
conception /conception/cat/1488/
condoms and lubricant /condoms-and-lubricant/cat/1621/
confidentiality, consent and medical ethics /confidentiality-consent-and-medical-ethics/cat/1687/
contraception /contraception/cat/1544/
delivery of care /delivery-of-care/cat/1519/
diabetes /diabetes/cat/1494/
diagnosing children /diagnosing-children/cat/1485/
disclosure and children /disclosure-and-children/cat/1484/
discrimination and the law /discrimination-and-the-law/cat/80324/
drug interactions and pharmacokinetics /drug-interactions-and-pharmacokinetics/cat/1465/
drug policy and policing /drug-policy-and-policing/cat/82203/
drug-resistant tb /drug-resistant-tb/cat/1503/
employment /employment/cat/1684/
end-of-life issues /end-of-life-issues/cat/1530/
epidemiology /epidemiology/cat/1682/
epidemiology and behaviour /epidemiology-and-behaviour/cat/1734/
exercise /exercise/cat/1478/
experiences of stigma /experiences-of-stigma/cat/80323/
families and children /families-and-children/cat/1482/
finance and funding /finance-and-funding/cat/1651/
finding support /finding-support/cat/1535/
global health initiatives /global-health-initiatives/cat/1650/
harm reduction /harm-reduction/cat/81851/
health monitoring /health-monitoring/cat/1655/
health monitoring in resource-limited settings /health-monitoring-in-resource-limited-settings/cat/1659/
health problems /health-problems/cat/1489/
health services and systems /health-services-and-systems/cat/1513/
healthy living /healthy-living/cat/1380/
hepatitis a /hepatitis-a/cat/1627/
hepatitis and hiv /hepatitis-and-hiv/cat/1508/
hepatitis b /hepatitis-b/cat/1510/
hepatitis c /hepatitis-c/cat/1509/
hepatitis c symptoms and diagnosis /hepatitis-c-symptoms-and-diagnosis/cat/1631/
hepatitis c transmission and prevention /hepatitis-c-transmission-and-prevention/cat/1628/
hepatitis c treatment /hepatitis-c-treatment/cat/1632/
hepatitis c treatment side-effects /hepatitis-c-treatment-side-effects/cat/80884/
history of hiv and aids /history-of-hiv-and-aids/cat/80327/
hiv and criminal law /hiv-and-criminal-law/cat/1686/
hiv and sex /hiv-and-sex/cat/1540/
hiv in children /hiv-in-children/cat/1660/
hiv prevention policy /hiv-prevention-policy/cat/80322/
hiv testing /hiv-testing/cat/1471/
hiv treatment /hiv-treatment/cat/1378/
hiv treatment in children /hiv-treatment-in-children/cat/1661/
how hiv causes disease /how-hiv-causes-disease/cat/1445/
how hiv works /how-hiv-works/cat/1440/
how transmission occurs /how-transmission-occurs/cat/1613/
human rights /human-rights/cat/80325/
immigration /immigration/cat/1527/
immunisations /immunisations/cat/1676/
infant feeding /infant-feeding/cat/1718/
infectiousness and treatment as prevention /infectiousness-and-treatment-as-prevention/cat/1624/
kidney problems /kidney-problems/cat/1723/
lipodystrophy /lipodystrophy/cat/1616/
living well with a low cd4 count /living-well-with-a-low-cd4-count/cat/1678/
low and theoretical transmission risks /low-and-theoretical-transmission-risks/cat/1618/
malaria /malaria/cat/1499/
malnutrition /malnutrition/cat/1642/
medical procedures and other blood-borne exposure /medical-procedures-and-other-blood-borne-exposure/cat/1617/
men who have sex with men (msm) /men-who-have-sex-with-men-msm/cat/1727/
mental and emotional health /mental-and-emotional-health/cat/1476/
mental and emotional health /mental-and-emotional-health/cat/1500/
microbicides /microbicides/cat/1453/
migrants /migrants/cat/1731/
money, benefits and housing /money-benefits-and-housing/cat/1529/
neurological and cognitive problems /neurological-and-cognitive-problems/cat/1719/
new and experimental hepatitis c treatment /new-and-experimental-hepatitis-c-treatment/cat/1635/
new and experimental hiv treatments /new-and-experimental-hiv-treatments/cat/1673/
nutrition /nutrition/cat/1480/
opportunistic infections /opportunistic-infections/cat/1495/
other tests /other-tests/cat/1658/
outcomes and prognosis /outcomes-and-prognosis/cat/1733/
palliative care /palliative-care/cat/1715/
people and personal stories /people-and-personal-stories/cat/82754/
people who inject drugs /people-who-inject-drugs/cat/1728/
pep /pep/cat/1455/
pharmaceutical industry /pharmaceutical-industry/cat/1646/
policy /policy/cat/1716/
populations /populations/cat/1726/
prep /prep/cat/1623/
prevention of mother-to-child transmission /prevention-of-mother-to-child-transmission/cat/1483/
prisoners /prisoners/cat/1730/
promoting hiv testing /promoting-hiv-testing/cat/1638/
recreational drug use /recreational-drug-use/cat/1477/
relationships and feelings /relationships-and-feelings/cat/1663/
religion and faith /religion-and-faith/cat/1644/
reproductive health /reproductive-health/cat/80812/
resistance /resistance/cat/1461/
retention and linkage to care /retention-and-linkage-to-care/cat/80814/
safer sex /safer-sex/cat/1546/
sex workers /sex-workers/cat/1729/
sexual transmission /sexual-transmission/cat/1614/
sexually transmitted infections /sexually-transmitted-infections/cat/1542/
side-effects /side-effects/cat/1463/
sleep /sleep/cat/1677/
smoking /smoking/cat/1481/
social and legal issues /social-and-legal-issues/cat/1525/
spermwashing /spermwashing/cat/1626/
starting treatment /starting-treatment/cat/1670/
structural factors /structural-factors/cat/80815/
support for families and children /support-for-families-and-children/cat/1662/
taking an hiv test /taking-an-hiv-test/cat/1637/
task shifting /task-shifting/cat/1717/
tb diagnosis /tb-diagnosis/cat/1504/
tb prevention /tb-prevention/cat/1668/
tb services /tb-services/cat/1505/
tb symptoms /tb-symptoms/cat/1669/
tb transmission /tb-transmission/cat/1667/
tb treatment /tb-treatment/cat/1506/
tb vaccine /tb-vaccine/cat/1666/
telling people you have hiv /telling-people-you-have-hiv/cat/1537/
testing and health monitoring /testing-and-health-monitoring/cat/1379/
testing policies and guidelines /testing-policies-and-guidelines/cat/1653/
the search for a cure /the-search-for-a-cure/cat/80321/
transgender people /transgender-people/cat/1528/
transmission and prevention /transmission-and-prevention/cat/1377/
travel /travel/cat/1688/
treatment for women /treatment-for-women/cat/1467/
treatment guidelines /treatment-guidelines/cat/1469/
treatment interruptions /treatment-interruptions/cat/1466/
treatment-experienced people /treatment-experienced-people/cat/1671/
tuberculosis and hiv /tuberculosis-and-hiv/cat/1502/
types of hiv tests /types-of-hiv-tests/cat/1649/
uk health services /uk-health-services/cat/1680/
vaccines /vaccines/cat/1459/
viral load /viral-load/cat/1657/
what is aids? /what-is-aids/cat/1443/
what is hiv? /what-is-hiv/cat/1444/
women /women/cat/1735/
young people /young-people/cat/1640/
abacavir (ziagen) /resources/treatmentsdirectory/drugs/abacavir-iziageni/page/1730880/
atazanavir (reyataz) /resources/treatmentsdirectory/drugs/atazanavir-ireyatazi/page/1730901/
atripla /resources/treatmentsdirectory/drugs/iatriplai/page/1730903/
darunavir (prezista) /resources/treatmentsdirectory/drugs/darunavir-iprezistai/page/1730953/
descovy /resources/treatmentsdirectory/drugs/idescovyi/page/3088857/
dolutegravir (tivicay) /resources/treatmentsdirectory/drugs/dolutegravir-itivicayi/page/2857993/
efavirenz (sustiva) /resources/treatmentsdirectory/drugs/efavirenz-isustivai/page/1730999/
elvitegravir (vitekta) /resources/treatmentsdirectory/drugs/elvitegravir-ivitektai/page/2858003/
emtricitabine (ftc, emtriva) /resources/treatmentsdirectory/drugs/emtricitabine-ftc-iemtrivai/page/1731063/
etravirine (intelence) /resources/treatmentsdirectory/drugs/etravirine-iintelencei/page/1731031/
eviplera /resources/treatmentsdirectory/drugs/ieviplerai/page/2188046/
evotaz /resources/treatmentsdirectory/drugs/ievotazi/page/3088910/
fosamprenavir (telzir, lexiva) /resources/treatmentsdirectory/drugs/fosamprenavir-itelziri-ilexivai/page/1731036/
genvoya /resources/treatmentsdirectory/drugs/igenvoyai/page/3088881/
kivexa (abacavir/3tc) /resources/treatmentsdirectory/drugs/ikivexai-abacavir3tc/page/1731081/
lamivudine (3tc, epivir) /resources/treatmentsdirectory/drugs/lamivudine-3tc-iepiviri/page/1730859/
lopinavir/ritonavir (kaletra) /resources/treatmentsdirectory/drugs/lopinavirritonavir-ikaletrai/page/1731082/
maraviroc (celsentri) /resources/treatmentsdirectory/drugs/maraviroc-icelsentrii/page/1731120/
nevirapine (viramune) /resources/treatmentsdirectory/drugs/nevirapine-iviramunei/page/1731152/
odefsey /resources/treatmentsdirectory/drugs/iodefseyi/page/3088883/
raltegravir (isentress) /resources/treatmentsdirectory/drugs/raltegravir-iisentressi/page/1731168/
rezolsta /resources/treatmentsdirectory/drugs/irezolstai/page/3088912/
rilpivirine (edurant) /resources/treatmentsdirectory/drugs/rilpivirine-ieduranti/page/1731269/
ritonavir (norvir) /resources/treatmentsdirectory/drugs/ritonavir-inorviri/page/1731169/
stribild /resources/treatmentsdirectory/drugs/istribildi/page/2857997/
tenofovir (viread) /resources/treatmentsdirectory/drugs/tenofovir-ivireadi/page/1731221/
triumeq /resources/treatmentsdirectory/drugs/itriumeqi/page/3088919/
truvada (tenofovir/ftc) /resources/treatmentsdirectory/drugs/itruvadai-tenofovirftc/page/1731265/
zidovudine (azt, retrovir) /resources/treatmentsdirectory/drugs/zidovudine-azt-iretroviri/page/1730919/
nam is the official scientific reporter for the 25th international harm reduction conference (hr17) /nam-is-the-official-scientific-reporter-for-the-25th-international-harm-reduction-conference-hr17/page/3108875/
start here – our factsheets on hiv prevention and treatment /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
world aids day /world-aids-day/page/3101205/
launch of about hiv / pro vich website /launch-of-about-hiv-pro-vich-website/page/3093196/
more /nam-blog
nam’s information /accessibility-terms-of-use/page/1404310/
subscribe to our news feeds /news/news-feeds/page/1444172/
get the latest hiv news delivered to your inbox /bulletins
sitemap /sitemap/page/1404305/
accessibility & terms of use /accessibility-terms-of-use/page/1404310/
privacy & cookies /privacy-amp-cookies/page/1404311/
feedback /feedback/page/1404313/
contact us /contact-us/page/1446756/

Linki zewnętrzne

nam http://www.aidsmap.com
aidsmap http://www.aidsmap.com
visit the official hr17 website https://www.hri.global/conference-2017
visit the about hiv / pro vich website http://www.about-hiv.info/
clinic portal http://clinic.nam.org.uk/page/2945735
the information standard certified member http://www.england.nhs.uk/tis/
sign the community consensus statement on access to hiv treatment and its use for prevention http://www.hivt4p.org/
community consensus statement on access to hiv treatment and its use for prevention http://www.hivt4p.org/
community consensus statement http://www.hivt4p.org
read it http://www.hivt4p.org/#content
sign it http://www.hivt4p.org/#profile-form
share it http://www.hivt4p.org/#share-links
http://www.avac.org/
http://www.eatg.org
http://msmgf.org/
http://www.gnpplus.net/
http://i-base.info/
http://www.aidsalliance.org/
http://itpcglobal.org/
http://www.aidsmap.com/

Zdjęcia

Zdjęcia 15
Zdjęcia bez atrybutu ALT 10
Zdjęcia bez atrybutu TITLE 15
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

/site/file/1213444/file.png
/v636108409673330000/file/1213110/resize/w106~c0,0,106,75/drug_chart_sep_2016_web_ready.png
/v635735895820000000/file/1187277/resize/w106~c0,0,106,75/your_next_steps_web.png
http://images.aidsmap.com/v636168829988770000/file/1213091/resize/w106~c0,0,106,75/hr17_images_1000_707_v2.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w106~c0,0,106,75/factsheets_1000px.png
http://images.aidsmap.com/v634550526142400000/file/1051735/resize/w106~c0,0,106,75/donate_to_nam_ribbon.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w297~c0,0,297,210/factsheets_1000px.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w114~c0,0,114,80/factsheets_1000px.png
http://images.aidsmap.com/v636168829988770000/file/1213091/resize/w114~c0,0,114,80/hr17_images_1000_707_v2.png
http://images.aidsmap.com/v636116944943700000/file/1213203/resize/w114~c0,0,114,80/prep.png
http://images.aidsmap.com/v636144661289100000/file/1213410/resize/w114~c0,0,114,80/2016_drugs_chart_1000px.png
http://images.aidsmap.com/v636124772830030000/file/1213309/resize/w114~c0,0,114,80/about_hiv_general_1000_707.png
http://maps.google.com/maps/api/staticmap?size=215x148&maptype=roadmap&sensor=false&center=mozambique&markers=icon:http://www.aidsmap.com/file/1051347/file.png|mozambique
/site/file/1213445/file.png
/site/file/1213446/file.png

Zdjęcia bez atrybutu ALT

/site/file/1213444/file.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w297~c0,0,297,210/factsheets_1000px.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w114~c0,0,114,80/factsheets_1000px.png
http://images.aidsmap.com/v636168829988770000/file/1213091/resize/w114~c0,0,114,80/hr17_images_1000_707_v2.png
http://images.aidsmap.com/v636116944943700000/file/1213203/resize/w114~c0,0,114,80/prep.png
http://images.aidsmap.com/v636144661289100000/file/1213410/resize/w114~c0,0,114,80/2016_drugs_chart_1000px.png
http://images.aidsmap.com/v636124772830030000/file/1213309/resize/w114~c0,0,114,80/about_hiv_general_1000_707.png
http://maps.google.com/maps/api/staticmap?size=215x148&maptype=roadmap&sensor=false&center=mozambique&markers=icon:http://www.aidsmap.com/file/1051347/file.png|mozambique
/site/file/1213445/file.png
/site/file/1213446/file.png

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

low graphics text only --> nam aidsmap hiv & aids - sharing knowledge, changing lives home news latest newspeople taking art in the uk have an accurate understanding of their viral load 12 hours agoimplants and injectables: prep in the future 13 january 2017risk of pregnancy loss among smokers much higher for women with hiv 11 january 2017featuresnew $90-$90-$90 target needed for global viral hepatitis, hiv and tb treatmentrings, films or inserts? researchers need to develop prevention products that make sense in women’s livespolicy makers' inaction is leading people to take prep 'in the wild'media reports of a british hiv cure 'breakthrough' are prematureeasl issues new hepatitis c treatment recommendations for all genotypes news by topic all our news, features and news selected from other sources. hiv update a fortnightly summary of hiv research news. news feeds conference news catch up on recent news reporting from hiv glasgow, the hiv research for prevention (r4p) conference and idweek. hiv basics hiv & aids what is hiv? and what is aids? find answers to some common questions in this section. transmission how is hiv transmitted - and how is it not transmitted? find out the answers in this section. testing worried you might have hiv? have an hiv test - it's the only way to know for sure. treatment hiv treatment is not a cure, but it is keeping millions of people well. start learning about it in this section. just diagnosed in this section we have answered some of the questions you might have if you have just found out you have hiv. looking for support in your area? find healthcare services and support. topics testing and health monitoring hiv testing | health monitoring hiv treatment treatment guidelines | starting treatment | side-effects | adherence | drug interactions and pharmacokinetics | treatment for women | resistance | changing treatment | treatment interruptions | treatment-experienced people | new and experimental hiv treatments | outcomes and prognosis | the search for a cure | bad science and bogus treatments transmission and prevention infectiousness and treatment as prevention | prep | how transmission occurs | sexual transmission | medical procedures and other blood-borne exposure | low and theoretical transmission risks | condoms and lubricant | harm reduction | circumcision | pep | behaviour change interventions | microbicides | vaccines | spermwashing | epidemiology and behaviour | hiv prevention policy | structural factors social and legal issues telling people you have hiv | finding support | hiv and criminal law | drug policy and policing | immigration | money, benefits and housing | employment | religion and faith | confidentiality, consent and medical ethics | travel | end-of-life issues | experiences of stigma | discrimination and the law | human rights | combatting stigma | history of hiv and aids | people and personal stories hepatitis and hiv hepatitis c | hepatitis b | hepatitis a families and children prevention of mother-to-child transmission | hiv treatment in children | infant feeding | conception | disclosure and children | diagnosing children | hiv in children | child developmental issues | support for families and children | reproductive health tuberculosis and hiv tb vaccine | tb transmission | tb prevention | tb symptoms | tb diagnosis | tb treatment | drug-resistant tb | tb services hiv and sex safer sex | relationships and feelings | contraception | sexually transmitted infections health services and systems delivery of care | task shifting | uk health services | palliative care | epidemiology | clinical trials | policy | activism | pharmaceutical industry | finance and funding | global health initiatives | access to medicines and treatment | retention and linkage to care | achieving the 90-90-90 target health problems kidney problems | ageing and hiv | mental and emotional health | opportunistic infections | cancer | cardiovascular disease | diabetes | malaria | neurological and cognitive problems | bone problems | lipodystrophy | malnutrition how hiv works what is hiv? | what is aids? | how hiv causes disease healthy living mental and emotional health | nutrition | exercise | recreational drug use | alcohol | smoking | complementary therapies | immunisations | sleep | living well with a low cd4 count view full list of topics resources featured resourcesantiretroviral drugs charta one-page reference guide to the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions.your next stepsa booklet with information for people who’ve just found out they have hiv. view a full list of nam's resources the basics an introduction to key issues about hiv treatment and living with hiv, presented as a series of illustrated leaflets. booklets our award-winning series of booklets, with each title providing a comprehensive overview of one aspect of living with hiv. apps and online tools a range of interactive tools to support people living with hiv to get involved in decisions about their treatment and care. antiretroviral drugs chart a one-page reference guide to the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions. translations arabic armenian dutch (nederlands) finnish (suomen kieli) french (français) georgian german (deutsch) hebrew italian (italiano) kazakh (қазақ) norwegian (norsk) polish (polski) portuguese (português) romanian (română) russian (русский) somali spanish (español) swedish (svenska) thai turkish (türk) ukrainian (yкраїнський) translating our resources e-atlas search for hiv services across the worldfind contact details for over 900 key organisations in more than 189 countriesget country-specific news and resourcesan instant guide to hiv & aids in countries and regions around the worldsearch for hiv services in the ukthe most comprehensive listing of hiv-related services in the uk about us nam blognam is the official scientific reporter for the 25th international harm reduction conference (hr17) 09 january 2017the 25th international harm reduction conference (hr17) is being held in montréal,...start here – our factsheets on hiv prevention and treatment 06 december 2016nam has just relaunched its series of hiv factsheets, covering some...world aids day 25 november 2016in the 1980s and 90s, even into the treatment era... who we are what we do maintaining high standards how you can support us how your support makes a difference confidentiality using nam’s resources contact us donate home nam works to change lives by sharing information about hiv and aids. we believe independent, clear and accurate information is vital in the fight against hiv and aids. more about us > start here – hiv factsheets nam has just relaunched its series of hiv factsheets, covering some of the most important topics in hiv prevention, treatment and care.each factsheet gives a brief overview of the key aspects of a topic, providing easy-to-understand information for individuals who want to take care of their health.visit our factsheets pagefind out more in our blog start here – hiv factsheets nam has just relaunched its series of hiv factsheets, covering some of the most important topics in hiv prevention, treatment and care.each factsheet gives a brief overview of the key aspects of a topic, providing easy-to-understand information for individuals who want to take care of their health.visit our factsheets pagefind out more in our blog nam is official hr17 scientific reporter the 25th international harm reduction conference (hr17) is being held in montréal, canada from 14-17 may 2017. nam is delighted to be the official scientific reporter for the conference, publishing news online and sending out a summary news bulletin the week following the conference.find out more in our blogsign up to receive the conference bulletinvisit the official hr17 website new prep trial for 2017 nhs england has announced that a major new three-year pre-exposure prophylaxis (prep) trial will start in 2017. it is planned to enrol at least 10,000 participants over the three years and nhs england will provide up to £10 million for the trial.read more about the trial in our news story read how to get prep in the ukread pre-exposure prophylaxis (prep) antiretroviral drugs chart a new edition of our antiretroviral drugs chart is now available online, and in print through our patient information scheme. this one-page reference guide lists all the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions.view the drugs chart online new website: about hiv / pro vich a new website (about hiv / pro vich) for people living with hiv in eastern europe and central asia was launched at the hiv glasgow conference. the website features a series of factsheets about key hiv topics, currently available in armenian, english, georgian, kazakh, russian and ukrainian. find out more on the nam blogvisit the about hiv / pro vich website sign up recently diagnosed clinic portal find an hiv service connect with nam aidsmap hiv & aids news people taking art in the uk have an accurate understanding of their viral load new viral load michael carter | 12 hours ago the vast majority of people taking antiretroviral therapy (art) in the uk have an accurate knowledge of their current viral load (vl) level, investigators report in hiv medicine. overall, 96% ... implants and injectables: prep in the future prep keith alcorn | 13 january 2017 last month’s announcement that the bill and melinda gates foundation will give up to $140 million to a boston drug device manufacturer to develop an implantable mini-pump to deliver drugs ... risk of pregnancy loss among smokers much higher for women with hiv smoking michael carter | 11 january 2017 smoking “dramatically” increases the risk of pregnancy loss – miscarriage or stillbirth – in hiv-positive women, us investigators report in the online edition of aids. researchers from the large women’s ... risk score accurately predicts which pregnant and postpartum women would benefit most from prep prep michael carter | 10 january 2017 a risk score based on routine assessments carried out during antenatal care in resource-limited settings can accurately predict which pregnant and breastfeeding women have an especially high risk of infection with hiv and ... nearly two-thirds of european hiv cases are now in russia epidemiology gus cairns | 09 january 2017 the annual number of new cases of hiv increased by at least 8% in 2015 in the whole of the world health organization (who) european region, and by 60% in the ... scaling up adult male circumcision calculated to have hiv prevention benefits additional to those seen with 90-90-90 treatment target circumcision michael carter | 05 january 2017 scale-up of voluntary medical male circumcision (vmmc) in countries with a high hiv prevalence has the potential to reduce incidence of new infections over and above the level associated with attainment of the ... viral load rebounds in a third of women who start hiv therapy during pregnancy or postpartum, south african study shows prevention of mother-to-child transmission michael carter | 04 january 2017 approximately one-third of hiv-positive women who attain viral suppression after starting antiretroviral therapy (art) during pregnancy experience a significant rebound in viral load in the year after giving birth, according to results of ... more news from aidsmap editor's picks from other sources the search for a cure converging roads between hiv and cancer research international aids society | 5 hours ago prep zimbabwe: zim to roll out pre-exposure hiv pill allafrica | 8 hours ago hiv and criminal law guide to prosecuting hiv cases ‘undermining’ public health, critics say toronto star | 12 hours ago hiv and criminal law criminalization of hiv non-disclosure a bigger burden on women, advocates say toronto star | 12 hours ago prep hiv diagnoses falling steeply, early figures show: london clinics see hope in increased use of pre-exposure prophylaxis financial times | 13 january 2017 harm reduction why addicts take drugs in 'fix rooms' bbc | 12 january 2017 smoking worried about hiv and aging? the first thing to do is stop smoking the body | 12 january 2017 hepatitis b european commission grants marketing authorization for gilead’s vemlidy® (tenofovir alafenamide, taf) for the treatment of chronic hepatitis b virus infection gilead press release | 12 january 2017 how transmission occurs bacterial communities of female genital tract impact hiv infection risk ragon institute | 12 january 2017 infectiousness and treatment as prevention london doctors on verge of defeating hiv thanks to new programme london evening standard | 11 january 2017 religion and faith knights of malta condom scandal stretches from myanmar to the vatican the guardian | 11 january 2017 activism fighting trump: hiv advocates to watch in 2017 my fabulous disease | 11 january 2017 more editor's picks e-atlas mozambique find news, resources and services from mozambique 6 services91 news articles58 editors' picks or select a country from the list below afghanistan Åland islands albania algeria american samoa andorra angola anguilla antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil brunei darussalam bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china and hong kong christmas island colombia comoros congo congo, the democratic republic of the cook islands costa rica côte d'ivoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands (malvinas) faroe islands fiji finland france french guiana french polynesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guinea-bissau guyana haiti honduras hungary iceland india indonesia iran, islamic republic of iraq ireland, republic of israel italy jamaica japan jordan kazakhstan kenya kiribati korea, democratic people's republic of korea, republic of kosovo kuwait kyrgyzstan lao people's democratic republic latvia lebanon lesotho liberia libyan arab jamahiriya liechtenstein lithuania luxembourg macao macedonia, the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia, federated states of moldova (republic of) monaco mongolia montenegro montserrat morocco mozambique namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestinian territory, occupied panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar réunion romania russian federation rwanda saint barthélemy saint kitts and nevis saint lucia saint martin saint pierre and miquelon saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa south sudan spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic tahiti - french polynesia taiwan tajikistan tanzania thailand timor-leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu venezuela viet nam virgin islands, british virgin islands, u.s. wallis and futuna western sahara yemen zambia zimbabwe a to z of topics access to medicines and treatment achieving the 90-90-90 target activism adherence africans in the uk ageing and hiv alcohol bad science and bogus treatments behaviour change interventions bone problems cancer cardiovascular disease cd4 count changing treatment child developmental issues circumcision clinical trials combatting stigma complementary therapies conception condoms and lubricant confidentiality, consent and medical ethics contraception delivery of care diabetes diagnosing children disclosure and children discrimination and the law drug interactions and pharmacokinetics drug policy and policing drug-resistant tb employment end-of-life issues epidemiology epidemiology and behaviour exercise experiences of stigma families and children finance and funding finding support global health initiatives harm reduction health monitoring health monitoring in resource-limited settings health problems health services and systems healthy living hepatitis a hepatitis and hiv hepatitis b hepatitis c hepatitis c symptoms and diagnosis hepatitis c transmission and prevention hepatitis c treatment hepatitis c treatment side-effects history of hiv and aids hiv and criminal law hiv and sex hiv in children hiv prevention policy hiv testing hiv treatment hiv treatment in children how hiv causes disease how hiv works how transmission occurs human rights immigration immunisations infant feeding infectiousness and treatment as prevention kidney problems lipodystrophy living well with a low cd4 count low and theoretical transmission risks malaria malnutrition medical procedures and other blood-borne exposure men who have sex with men (msm) mental and emotional health mental and emotional health microbicides migrants money, benefits and housing neurological and cognitive problems new and experimental hepatitis c treatment new and experimental hiv treatments nutrition opportunistic infections other tests outcomes and prognosis palliative care people and personal stories people who inject drugs pep pharmaceutical industry policy populations prep prevention of mother-to-child transmission prisoners promoting hiv testing recreational drug use relationships and feelings religion and faith reproductive health resistance retention and linkage to care safer sex sex workers sexual transmission sexually transmitted infections side-effects sleep smoking social and legal issues spermwashing starting treatment structural factors support for families and children taking an hiv test task shifting tb diagnosis tb prevention tb services tb symptoms tb transmission tb treatment tb vaccine telling people you have hiv testing and health monitoring testing policies and guidelines the search for a cure transgender people transmission and prevention travel treatment for women treatment guidelines treatment interruptions treatment-experienced people tuberculosis and hiv types of hiv tests uk health services vaccines viral load what is aids? what is hiv? women young people a to z of drugs abacavir (ziagen) atazanavir (reyataz) atripla darunavir (prezista) descovy dolutegravir (tivicay) efavirenz (sustiva) elvitegravir (vitekta) emtricitabine (ftc, emtriva) etravirine (intelence) eviplera evotaz fosamprenavir (telzir, lexiva) genvoya kivexa (abacavir/3tc) lamivudine (3tc, epivir) lopinavir/ritonavir (kaletra) maraviroc (celsentri) nevirapine (viramune) odefsey raltegravir (isentress) rezolsta rilpivirine (edurant) ritonavir (norvir) stribild tenofovir (viread) triumeq truvada (tenofovir/ftc) zidovudine (azt, retrovir) nam blog nam is the official scientific reporter for the 25th international harm reduction conference (hr17) 09 january 2017 start here – our factsheets on hiv prevention and treatment 06 december 2016 world aids day 25 november 2016 launch of about hiv / pro vich website 23 october 2016 more the information standard certified member nam’s information is intended to support, rather than replace, consultation with a healthcare professional. talk to your doctor or another member of your healthcare team for advice tailored to your situation. aidsmap news feeds subscribe to our news feeds email updates get the latest hiv news delivered to your inbox share/bookmark this page   facebook   twitter   stumbleupon   linkedin   reddit   digg   delicious   technorati   g bookmarks   y! bookmarks --> nam publications registered office: acorn house, 314-320 gray’s inn road, london, wc1x 8dp company limited by guarantee. registered in england & wales, number: 2707596 registered charity, number: 1011220 © nam publications, 2017. all rights reserved. nam is not responsible for the content of external websites. sitemapaccessibility & terms of useprivacy & cookiesfeedbackcontact usmobile version--> sign the community consensus statement on access to hiv treatment and its use for prevention more community consensus statement on access to hiv treatment and its use for prevention together, we can make it happen we can end hiv soon if people have equal access to hiv drugs as treatment and as prep, and have free choice over whether to take them. launched today, the community consensus statement is a basic set of principles aimed at making sure that happens. read it sign it share it the community consensus statement is a joint initiative of avac, eatg, msmgf, gnp+, hiv i-base, the international hiv/aids alliance, itpc and nam/aidsmap close this content was checked for accuracy at the time it was written. it may have been superseded by more recent developments. nam recommends checking whether this is the most current information when making decisions that may affect your health. nam’s information is intended to support, rather than replace, consultation with a healthcare professional. talk to your doctor or another member of your healthcare team for advice tailored to your situation.


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 3293

One word

Two words phrases

Three words phrases

and - 5.25% (173)
the - 3.74% (123)
hiv - 3.37% (111)
men - 2.73% (90)
for - 1.67% (55)
our - 1.43% (47)
treatment - 1.4% (46)
new - 1.12% (37)
pro - 0.97% (32)
health - 0.94% (31)
art - 0.94% (31)
out - 0.91% (30)
nam - 0.82% (27)
even - 0.73% (24)
are - 0.7% (23)
2017 - 0.7% (23)
prevention - 0.67% (22)
drug - 0.67% (22)
with - 0.64% (21)
aids - 0.64% (21)
people - 0.61% (20)
news - 0.61% (20)
jan - 0.61% (20)
you - 0.58% (19)
can - 0.58% (19)
have - 0.55% (18)
january - 0.55% (18)
hepatitis - 0.52% (17)
child - 0.52% (17)
care - 0.52% (17)
transmission - 0.49% (16)
all - 0.49% (16)
viral - 0.46% (15)
public - 0.46% (15)
prep - 0.46% (15)
how - 0.43% (14)
drugs - 0.39% (13)
test - 0.39% (13)
information - 0.39% (13)
service - 0.39% (13)
one - 0.39% (13)
about - 0.39% (13)
island - 0.39% (13)
women - 0.39% (13)
more - 0.36% (12)
republic - 0.36% (12)
use - 0.36% (12)
star - 0.36% (12)
find - 0.36% (12)
children - 0.36% (12)
factsheet - 0.36% (12)
services - 0.36% (12)
harm - 0.33% (11)
your - 0.33% (11)
support - 0.33% (11)
islands - 0.33% (11)
over - 0.33% (11)
sure - 0.33% (11)
... - 0.3% (10)
conference - 0.3% (10)
search - 0.3% (10)
factsheets - 0.3% (10)
end - 0.3% (10)
other - 0.3% (10)
from - 0.3% (10)
sex - 0.3% (10)
who - 0.3% (10)
start - 0.3% (10)
topic - 0.27% (9)
key - 0.27% (9)
risk - 0.27% (9)
rica - 0.27% (9)
mental - 0.27% (9)
sources - 0.27% (9)
get - 0.27% (9)
count - 0.24% (8)
this - 0.24% (8)
infection - 0.24% (8)
report - 0.24% (8)
ago - 0.24% (8)
issues - 0.24% (8)
its - 0.24% (8)
problems - 0.24% (8)
living - 0.24% (8)
guide - 0.24% (8)
reduction - 0.21% (7)
policy - 0.21% (7)
law - 0.21% (7)
website - 0.21% (7)
resources - 0.21% (7)
europe - 0.21% (7)
low - 0.21% (7)
testing - 0.21% (7)
what - 0.21% (7)
load - 0.21% (7)
just - 0.18% (6)
antiretroviral - 0.18% (6)
saint - 0.18% (6)
trial - 0.18% (6)
exposure - 0.18% (6)
hr17 - 0.18% (6)
view - 0.18% (6)
blog - 0.18% (6)
launch - 0.18% (6)
page - 0.18% (6)
- 0.18% (6)
international - 0.18% (6)
access - 0.18% (6)
here - 0.18% (6)
hours - 0.18% (6)
series - 0.18% (6)
smoking - 0.18% (6)
european - 0.18% (6)
not - 0.18% (6)
topics - 0.18% (6)
accurate - 0.18% (6)
their - 0.18% (6)
side-effects - 0.18% (6)
that - 0.15% (5)
michael - 0.15% (5)
cure - 0.15% (5)
sign - 0.15% (5)
criminal - 0.15% (5)
take - 0.15% (5)
launched - 0.15% (5)
was - 0.15% (5)
list - 0.15% (5)
now - 0.15% (5)
read - 0.15% (5)
infections - 0.15% (5)
aidsmap - 0.15% (5)
africa - 0.15% (5)
most - 0.15% (5)
develop - 0.15% (5)
chart - 0.15% (5)
official - 0.15% (5)
pregnancy - 0.15% (5)
2016 - 0.15% (5)
high - 0.15% (5)
disease - 0.15% (5)
has - 0.15% (5)
online - 0.15% (5)
carter - 0.15% (5)
may - 0.15% (5)
epidemiology - 0.15% (5)
circumcision - 0.15% (5)
healthcare - 0.15% (5)
monitoring - 0.15% (5)
some - 0.15% (5)
arab - 0.15% (5)
experience - 0.15% (5)
world - 0.15% (5)
medical - 0.15% (5)
research - 0.15% (5)
deliver - 0.12% (4)
clinic - 0.12% (4)
hiv? - 0.12% (4)
(hr17) - 0.12% (4)
treatments - 0.12% (4)
25th - 0.12% (4)
behaviour - 0.12% (4)
scientific - 0.12% (4)
than - 0.12% (4)
community - 0.12% (4)
french - 0.12% (4)
target - 0.12% (4)
guinea - 0.12% (4)
london - 0.12% (4)
emotional - 0.12% (4)
consensus - 0.12% (4)
transmitted - 0.12% (4)
taking - 0.12% (4)
statement - 0.12% (4)
nutrition - 0.12% (4)
section - 0.12% (4)
vaccine - 0.12% (4)
reporter - 0.12% (4)
pre-exposure - 0.12% (4)
benefit - 0.12% (4)
make - 0.12% (4)
vich - 0.12% (4)
sexual - 0.12% (4)
stigma - 0.12% (4)
families - 0.12% (4)
russia - 0.12% (4)
standard - 0.09% (3)
aspect - 0.09% (3)
million - 0.09% (3)
will - 0.09% (3)
story - 0.09% (3)
current - 0.09% (3)
overview - 0.09% (3)
prophylaxis - 0.09% (3)
care. - 0.09% (3)
providing - 0.09% (3)
each - 0.09% (3)
mali - 0.09% (3)
booklet - 0.09% (3)
therapy - 0.09% (3)
food - 0.09% (3)
condom - 0.09% (3)
inject - 0.09% (3)
initiative - 0.09% (3)
mozambique - 0.09% (3)
one-page - 0.09% (3)
reference - 0.09% (3)
set - 0.09% (3)
anti-hiv - 0.09% (3)
georgia - 0.09% (3)
basic - 0.09% (3)
licensed - 0.09% (3)
democratic - 0.09% (3)
oman - 0.09% (3)
formulation, - 0.09% (3)
dosing, - 0.09% (3)
san - 0.09% (3)
aids. - 0.09% (3)
zim - 0.09% (3)
inn - 0.09% (3)
using - 0.09% (3)
confidentiality - 0.09% (3)
number - 0.09% (3)
give - 0.09% (3)
gus - 0.09% (3)
member - 0.09% (3)
doctor - 0.09% (3)
day - 0.09% (3)
covering - 0.09% (3)
factsheets, - 0.09% (3)
male - 0.09% (3)
registered - 0.09% (3)
relaunched - 0.09% (3)
third - 0.09% (3)
tenofovir - 0.09% (3)
restrictions. - 0.09% (3)
countries - 0.09% (3)
nam’s - 0.09% (3)
kazakh - 0.09% (3)
england - 0.09% (3)
russian - 0.09% (3)
contact - 0.09% (3)
limited - 0.09% (3)
picks - 0.09% (3)
south - 0.09% (3)
year - 0.09% (3)
during - 0.09% (3)
cases - 0.09% (3)
2017. - 0.09% (3)
armenia - 0.09% (3)
united - 0.09% (3)
african - 0.09% (3)
union, - 0.09% (3)
health. - 0.09% (3)
guidelines - 0.09% (3)
activism - 0.09% (3)
symptoms - 0.09% (3)
diagnosis - 0.09% (3)
hiv. - 0.09% (3)
bad - 0.09% (3)
90-90-90 - 0.09% (3)
benefits - 0.09% (3)
recent - 0.09% (3)
occurs - 0.09% (3)
feeds - 0.09% (3)
experimental - 0.09% (3)
religion - 0.09% (3)
faith - 0.09% (3)
global - 0.09% (3)
rights - 0.09% (3)
features - 0.09% (3)
starting - 0.09% (3)
infectiousness - 0.09% (3)
cancer - 0.09% (3)
found - 0.09% (3)
cd4 - 0.09% (3)
well - 0.09% (3)
change - 0.09% (3)
--> - 0.09% (3)
section. - 0.09% (3)
mother-to-child - 0.09% (3)
changing - 0.09% (3)
loss - 0.09% (3)
know - 0.09% (3)
lives - 0.09% (3)
feeding - 0.09% (3)
aids? - 0.09% (3)
disclosure - 0.09% (3)
works - 0.09% (3)
country - 0.06% (2)
early - 0.06% (2)
see - 0.06% (2)
select - 0.06% (2)
grants - 0.06% (2)
(tenofovir - 0.06% (2)
diagnosed - 0.06% (2)
gilead - 0.06% (2)
way - 0.06% (2)
malta - 0.06% (2)
samoa - 0.06% (2)
press - 0.06% (2)
advocates - 0.06% (2)
treatment-experienced - 0.06% (2)
adherence - 0.06% (2)
bogus - 0.06% (2)
accurately - 0.06% (2)
which - 0.06% (2)
pregnant - 0.06% (2)
postpartum - 0.06% (2)
condoms - 0.06% (2)
risks - 0.06% (2)
resource-limited - 0.06% (2)
settings - 0.06% (2)
predict - 0.06% (2)
theoretical - 0.06% (2)
blood-borne - 0.06% (2)
procedures - 0.06% (2)
increased - 0.06% (2)
science - 0.06% (2)
toronto - 0.06% (2)
level - 0.06% (2)
prognosis - 0.06% (2)
outcomes - 0.06% (2)
attain - 0.06% (2)
after - 0.06% (2)
rebound - 0.06% (2)
congo - 0.06% (2)
editor's - 0.06% (2)
interruptions - 0.06% (2)
resistance - 0.06% (2)
pharmacokinetics - 0.06% (2)
interactions - 0.06% (2)
say - 0.06% (2)
might - 0.06% (2)
korea, - 0.06% (2)
worried - 0.06% (2)
publications - 0.06% (2)
replace, - 0.06% (2)
consultation - 0.06% (2)
professional. - 0.06% (2)
talk - 0.06% (2)
much - 0.06% (2)
another - 0.06% (2)
team - 0.06% (2)
advice - 0.06% (2)
tailored - 0.06% (2)
situation. - 0.06% (2)
smokers - 0.06% (2)
bookmarks - 0.06% (2)
among - 0.06% (2)
support, - 0.06% (2)
future - 0.06% (2)
number: - 0.06% (2)
content - 0.06% (2)
injectables: - 0.06% (2)
understanding - 0.06% (2)
latest - 0.06% (2)
happen - 0.06% (2)
home - 0.06% (2)
whether - 0.06% (2)
making - 0.06% (2)
sharing - 0.06% (2)
share - 0.06% (2)
time - 0.06% (2)
rather - 0.06% (2)
intended - 0.06% (2)
cook - 0.06% (2)
summary - 0.06% (2)
dominica - 0.06% (2)
questions - 0.06% (2)
polynesia - 0.06% (2)
answers - 0.06% (2)
women, - 0.06% (2)
people's - 0.06% (2)
basics - 0.06% (2)
states - 0.06% (2)
netherlands - 0.06% (2)
niger - 0.06% (2)
romania - 0.06% (2)
martin - 0.06% (2)
update - 0.06% (2)
higher - 0.06% (2)
sudan - 0.06% (2)
news, - 0.06% (2)
virgin - 0.06% (2)
islands, - 0.06% (2)
zimbabwe - 0.06% (2)
british - 0.06% (2)
tests - 0.06% (2)
women’s - 0.06% (2)
types - 0.06% (2)
abacavir - 0.06% (2)
ritonavir - 0.06% (2)
need - 0.06% (2)
researchers - 0.06% (2)
score - 0.06% (2)
full - 0.06% (2)
hiv-positive - 0.06% (2)
palliative - 0.06% (2)
medicines - 0.06% (2)
initiatives - 0.06% (2)
somali - 0.06% (2)
thai - 0.06% (2)
ukrainian - 0.06% (2)
e-atlas - 0.06% (2)
funding - 0.06% (2)
finance - 0.06% (2)
industry - 0.06% (2)
pharmaceutical - 0.06% (2)
resourcesan - 0.06% (2)
trials - 0.06% (2)
clinical - 0.06% (2)
shifting - 0.06% (2)
german - 0.06% (2)
task - 0.06% (2)
delivery - 0.06% (2)
systems - 0.06% (2)
being - 0.06% (2)
held - 0.06% (2)
sexually - 0.06% (2)
contraception - 0.06% (2)
feelings - 0.06% (2)
december - 0.06% (2)
relationships - 0.06% (2)
safer - 0.06% (2)
drug-resistant - 0.06% (2)
tuberculosis - 0.06% (2)
italian - 0.06% (2)
georgian - 0.06% (2)
reproductive - 0.06% (2)
cognitive - 0.06% (2)
sleep - 0.06% (2)
immunisations - 0.06% (2)
therapies - 0.06% (2)
complementary - 0.06% (2)
alcohol - 0.06% (2)
recreational - 0.06% (2)
exercise - 0.06% (2)
only - 0.06% (2)
healthy - 0.06% (2)
causes - 0.06% (2)
malnutrition - 0.06% (2)
lipodystrophy - 0.06% (2)
bone - 0.06% (2)
booklets - 0.06% (2)
retention - 0.06% (2)
neurological - 0.06% (2)
malaria - 0.06% (2)
comprehensive - 0.06% (2)
diabetes - 0.06% (2)
cardiovascular - 0.06% (2)
opportunistic - 0.06% (2)
tools - 0.06% (2)
ageing - 0.06% (2)
decisions - 0.06% (2)
kidney - 0.06% (2)
achieving - 0.06% (2)
linkage - 0.06% (2)
armenian - 0.06% (2)
november - 0.06% (2)
developmental - 0.06% (2)
lubricant - 0.06% (2)
conference. - 0.06% (2)
least - 0.06% (2)
three - 0.06% (2)
confidentiality, - 0.06% (2)
edition - 0.06% (2)
employment - 0.06% (2)
available - 0.06% (2)
through - 0.06% (2)
housing - 0.06% (2)
money, - 0.06% (2)
central - 0.06% (2)
immigration - 0.06% (2)
policing - 0.06% (2)
glasgow - 0.06% (2)
finding - 0.06% (2)
(prep) - 0.06% (2)
telling - 0.06% (2)
legal - 0.06% (2)
social - 0.06% (2)
factors - 0.06% (2)
structural - 0.06% (2)
spermwashing - 0.06% (2)
(art) - 0.06% (2)
knowledge - 0.06% (2)
investigators - 0.06% (2)
microbicides - 0.06% (2)
interventions - 0.06% (2)
implants - 0.06% (2)
pep - 0.06% (2)
consent - 0.06% (2)
ethics - 0.06% (2)
diagnosing - 0.06% (2)
want - 0.06% (2)
conception - 0.06% (2)
infant - 0.06% (2)
fight - 0.06% (2)
important - 0.06% (2)
prevention, - 0.06% (2)
care.each - 0.06% (2)
stories - 0.06% (2)
gives - 0.06% (2)
brief - 0.06% (2)
aspects - 0.06% (2)
topic, - 0.06% (2)
easy-to-understand - 0.06% (2)
individuals - 0.06% (2)
health.visit - 0.06% (2)
travel - 0.06% (2)
pagefind - 0.06% (2)
personal - 0.06% (2)
history - 0.06% (2)
montréal, - 0.06% (2)
canada - 0.06% (2)
combatting - 0.06% (2)
bulletin - 0.06% (2)
week - 0.06% (2)
human - 0.06% (2)
discrimination - 0.06% (2)
experiences - 0.06% (2)
nhs - 0.06% (2)
end-of-life - 0.06% (2)
major - 0.06% (2)
vaccines - 0.06% (2)
in the - 0.61% (20)
january 2017 - 0.55% (18)
hiv and - 0.43% (14)
of the - 0.39% (13)
of hiv - 0.33% (11)
hiv treatment - 0.3% (10)
hepatitis c - 0.24% (8)
treatment and - 0.21% (7)
about hiv - 0.21% (7)
with hiv - 0.21% (7)
republic of - 0.21% (7)
and treatment - 0.21% (7)
harm reduction - 0.21% (7)
hiv prevention - 0.21% (7)
viral load - 0.21% (7)
hiv test - 0.21% (7)
the uk - 0.21% (7)
series of - 0.18% (6)
and hiv - 0.18% (6)
for the - 0.18% (6)
and children - 0.18% (6)
have an - 0.18% (6)
what is - 0.18% (6)
search for - 0.18% (6)
hours ago - 0.18% (6)
with a - 0.18% (6)
and the - 0.15% (5)
drugs chart - 0.15% (5)
hiv in - 0.15% (5)
children | - 0.15% (5)
michael carter - 0.15% (5)
health monitoring - 0.15% (5)
to your - 0.15% (5)
nam is - 0.15% (5)
carter | - 0.15% (5)
11 january - 0.15% (5)
find out - 0.15% (5)
access to - 0.15% (5)
hiv factsheets - 0.15% (5)
of their - 0.15% (5)
treatment in - 0.12% (4)
the official - 0.12% (4)
in our - 0.12% (4)
in children - 0.12% (4)
and aids - 0.12% (4)
families and - 0.12% (4)
c treatment - 0.12% (4)
antiretroviral drugs - 0.12% (4)
hepatitis b - 0.12% (4)
out more - 0.12% (4)
pro vich - 0.12% (4)
risk of - 0.12% (4)
mental and - 0.12% (4)
emotional health - 0.12% (4)
how hiv - 0.12% (4)
and emotional - 0.12% (4)
for women - 0.12% (4)
to hiv - 0.12% (4)
here – - 0.12% (4)
25th international - 0.12% (4)
reduction conference - 0.12% (4)
and criminal - 0.12% (4)
international harm - 0.12% (4)
the 25th - 0.12% (4)
to the - 0.12% (4)
conference (hr17) - 0.12% (4)
criminal law - 0.12% (4)
the most - 0.12% (4)
living with - 0.12% (4)
in hiv - 0.12% (4)
with information - 0.12% (4)
guide to - 0.12% (4)
12 january - 0.12% (4)
consensus statement - 0.12% (4)
an accurate - 0.12% (4)
you have - 0.12% (4)
12 hours - 0.12% (4)
an hiv - 0.12% (4)
start here - 0.12% (4)
& aids - 0.12% (4)
a cure - 0.12% (4)
in this - 0.12% (4)
community consensus - 0.12% (4)
hiv drugs - 0.12% (4)
hiv testing - 0.12% (4)
is hiv - 0.12% (4)
the anti-hiv - 0.09% (3)
one-page reference - 0.09% (3)
cd4 count - 0.09% (3)
| treatment - 0.09% (3)
how transmission - 0.09% (3)
for use - 0.09% (3)
transmission and - 0.09% (3)
is aids? - 0.09% (3)
is hiv? - 0.09% (3)
as prevention - 0.09% (3)
just relaunched - 0.09% (3)
its series - 0.09% (3)
some of - 0.09% (3)
transmission occurs - 0.09% (3)
drugs licensed - 0.09% (3)
dosing, key - 0.09% (3)
european union, - 0.09% (3)
licensed for - 0.09% (3)
official scientific - 0.09% (3)
reporter for - 0.09% (3)
and food - 0.09% (3)
key side-effects - 0.09% (3)
formulation, dosing, - 0.09% (3)
information on - 0.09% (3)
union, with - 0.09% (3)
the european - 0.09% (3)
use in - 0.09% (3)
anti-hiv drugs - 0.09% (3)
on formulation, - 0.09% (3)
| drug - 0.09% (3)
reference guide - 0.09% (3)
overview of - 0.09% (3)
and faith - 0.09% (3)
and experimental - 0.09% (3)
services and - 0.09% (3)
information for - 0.09% (3)
side-effects and - 0.09% (3)
news feeds - 0.09% (3)
factsheets, covering - 0.09% (3)
problems | - 0.09% (3)
is the - 0.09% (3)
tb treatment - 0.09% (3)
mother-to-child transmission - 0.09% (3)
of pregnancy - 0.09% (3)
more in - 0.09% (3)
pregnancy loss - 0.09% (3)
pre-exposure prophylaxis - 0.09% (3)
people a - 0.09% (3)
and prevention - 0.09% (3)
prep in - 0.09% (3)
this section. - 0.09% (3)
our news - 0.09% (3)
prevention of - 0.09% (3)
13 january - 0.09% (3)
the community - 0.09% (3)
nam has - 0.09% (3)
uk have - 0.09% (3)
art in - 0.09% (3)
of mother-to-child - 0.09% (3)
2017 a - 0.09% (3)
people taking - 0.09% (3)
new and - 0.09% (3)
religion and - 0.09% (3)
transmission | - 0.09% (3)
women who - 0.06% (2)
member of - 0.06% (2)
your healthcare - 0.06% (2)
the future - 0.06% (2)
antiretroviral therapy - 0.06% (2)
report in - 0.06% (2)
and injectables: - 0.06% (2)
pregnant and - 0.06% (2)
team for - 0.06% (2)
the ... - 0.06% (2)
at least - 0.06% (2)
nam publications - 0.06% (2)
is not - 0.06% (2)
resource-limited settings - 0.06% (2)
which pregnant - 0.06% (2)
risk score - 0.06% (2)
investigators report - 0.06% (2)
2017 smoking - 0.06% (2)
male circumcision - 0.06% (2)
we can - 0.06% (2)
of new - 0.06% (2)
during pregnancy - 0.06% (2)
statement on - 0.06% (2)
much higher - 0.06% (2)
among smokers - 0.06% (2)
advice tailored - 0.06% (2)
therapy (art) - 0.06% (2)
use for - 0.06% (2)
and its - 0.06% (2)
safer sex - 0.06% (2)
in viral - 0.06% (2)
theoretical transmission - 0.06% (2)
experiences of - 0.06% (2)
finance and - 0.06% (2)
in resource-limited - 0.06% (2)
25 november - 0.06% (2)
aids day - 0.06% (2)
and health - 0.06% (2)
hiv works - 0.06% (2)
tb vaccine - 0.06% (2)
kidney problems - 0.06% (2)
tb prevention - 0.06% (2)
tb diagnosis - 0.06% (2)
task shifting - 0.06% (2)
low and - 0.06% (2)
taking an - 0.06% (2)
and pharmacokinetics - 0.06% (2)
procedures and - 0.06% (2)
other blood-borne - 0.06% (2)
money, benefits - 0.06% (2)
and housing - 0.06% (2)
for families - 0.06% (2)
neurological and - 0.06% (2)
cognitive problems - 0.06% (2)
sexual transmission - 0.06% (2)
experimental hiv - 0.06% (2)
opportunistic infections - 0.06% (2)
outcomes and - 0.06% (2)
and personal - 0.06% (2)
drug use - 0.06% (2)
drug-resistant tb - 0.06% (2)
drug interactions - 0.06% (2)
editor's picks - 0.06% (2)
from the - 0.06% (2)
from other - 0.06% (2)
or another - 0.06% (2)
sources the - 0.06% (2)
your doctor - 0.06% (2)
talk to - 0.06% (2)
toronto star - 0.06% (2)
healthcare professional. - 0.06% (2)
replace, consultation - 0.06% (2)
say toronto - 0.06% (2)
rather than - 0.06% (2)
star | - 0.06% (2)
ago prep - 0.06% (2)
to support, - 0.06% (2)
is intended - 0.06% (2)
the law - 0.06% (2)
french polynesia - 0.06% (2)
democratic republic - 0.06% (2)
virgin islands, - 0.06% (2)
nam’s information - 0.06% (2)
achieving the - 0.06% (2)
90-90-90 target - 0.06% (2)
bad science - 0.06% (2)
and bogus - 0.06% (2)
change interventions - 0.06% (2)
developmental issues - 0.06% (2)
consent and - 0.06% (2)
medical ethics - 0.06% (2)
discrimination and - 0.06% (2)
condoms and - 0.06% (2)
--> nam - 0.06% (2)
their viral - 0.06% (2)
end-of-life issues - 0.06% (2)
behaviour change - 0.06% (2)
epidemiology and - 0.06% (2)
policy | - 0.06% (2)
structural factors - 0.06% (2)
social and - 0.06% (2)
legal issues - 0.06% (2)
telling people - 0.06% (2)
finding support - 0.06% (2)
drug policy - 0.06% (2)
and policing - 0.06% (2)
benefits and - 0.06% (2)
confidentiality, consent - 0.06% (2)
and medical - 0.06% (2)
of stigma - 0.06% (2)
transmission risks - 0.06% (2)
human rights - 0.06% (2)
stigma | - 0.06% (2)
history of - 0.06% (2)
people and - 0.06% (2)
personal stories - 0.06% (2)
hepatitis and - 0.06% (2)
hiv hepatitis - 0.06% (2)
| hepatitis - 0.06% (2)
a families - 0.06% (2)
infant feeding - 0.06% (2)
child developmental - 0.06% (2)
issues | - 0.06% (2)
support for - 0.06% (2)
reproductive health - 0.06% (2)
and lubricant - 0.06% (2)
and theoretical - 0.06% (2)
tb transmission - 0.06% (2)
just found - 0.06% (2)
accurate understanding - 0.06% (2)
injectables: prep - 0.06% (2)
loss among - 0.06% (2)
smokers much - 0.06% (2)
higher for - 0.06% (2)
women with - 0.06% (2)
to develop - 0.06% (2)
hiv research - 0.06% (2)
the hiv - 0.06% (2)
might have - 0.06% (2)
treatment hiv - 0.06% (2)
of people - 0.06% (2)
you might - 0.06% (2)
have hiv. - 0.06% (2)
blood-borne exposure - 0.06% (2)
testing and - 0.06% (2)
monitoring hiv - 0.06% (2)
starting treatment - 0.06% (2)
interactions and - 0.06% (2)
treatment for - 0.06% (2)
changing treatment - 0.06% (2)
treatment-experienced people - 0.06% (2)
hiv treatments - 0.06% (2)
and prognosis - 0.06% (2)
science and - 0.06% (2)
bogus treatments - 0.06% (2)
| sexual - 0.06% (2)
medical procedures - 0.06% (2)
and other - 0.06% (2)
tuberculosis and - 0.06% (2)
prevention | - 0.06% (2)
understanding of - 0.06% (2)
aspects of - 0.06% (2)
held in - 0.06% (2)
– our - 0.06% (2)
factsheets on - 0.06% (2)
06 december - 0.06% (2)
day 25 - 0.06% (2)
the treatment - 0.06% (2)
how you - 0.06% (2)
important topics - 0.06% (2)
prevention, treatment - 0.06% (2)
and care.each - 0.06% (2)
factsheet gives - 0.06% (2)
a brief - 0.06% (2)
the key - 0.06% (2)
a topic, - 0.06% (2)
aidsmap hiv - 0.06% (2)
providing easy-to-understand - 0.06% (2)
individuals who - 0.06% (2)
want to - 0.06% (2)
take care - 0.06% (2)
health.visit our - 0.06% (2)
factsheets pagefind - 0.06% (2)
blog nam - 0.06% (2)
nhs england - 0.06% (2)
about the - 0.06% (2)
prophylaxis (prep) - 0.06% (2)
chart a - 0.06% (2)
for people - 0.06% (2)
features a - 0.06% (2)
taking art - 0.06% (2)
is being - 0.06% (2)
about us - 0.06% (2)
tb symptoms - 0.06% (2)
ageing and - 0.06% (2)
tb services - 0.06% (2)
relationships and - 0.06% (2)
sexually transmitted - 0.06% (2)
of care - 0.06% (2)
uk health - 0.06% (2)
palliative care - 0.06% (2)
| epidemiology - 0.06% (2)
pharmaceutical industry - 0.06% (2)
and funding - 0.06% (2)
health initiatives - 0.06% (2)
to medicines - 0.06% (2)
and linkage - 0.06% (2)
to care - 0.06% (2)
the 90-90-90 - 0.06% (2)
cardiovascular disease - 0.06% (2)
services in - 0.06% (2)
and cognitive - 0.06% (2)
bone problems - 0.06% (2)
hiv causes - 0.06% (2)
health | - 0.06% (2)
recreational drug - 0.06% (2)
complementary therapies - 0.06% (2)
well with - 0.06% (2)
list of - 0.06% (2)
full list - 0.06% (2)
hiv to - 0.06% (2)
a one-page - 0.06% (2)
for hiv - 0.06% (2)
in countries - 0.06% (2)
hiv services - 0.06% (2)
(hr17) 09 - 0.06% (2)
in the uk - 0.21% (7)
11 january 2017 - 0.15% (5)
michael carter | - 0.15% (5)
| 11 january - 0.12% (4)
community consensus statement - 0.12% (4)
the 25th international - 0.12% (4)
start here – - 0.12% (4)
hiv and criminal - 0.12% (4)
| 12 january - 0.12% (4)
12 january 2017 - 0.12% (4)
and criminal law - 0.12% (4)
families and children - 0.12% (4)
hiv and aids - 0.12% (4)
harm reduction conference - 0.12% (4)
in this section - 0.12% (4)
about hiv / - 0.12% (4)
hiv / pro - 0.12% (4)
international harm reduction - 0.12% (4)
living with hiv - 0.12% (4)
hiv & aids - 0.12% (4)
and emotional health - 0.12% (4)
the anti-hiv drugs - 0.09% (3)
of pregnancy loss - 0.09% (3)
formulation, dosing, key - 0.09% (3)
side-effects and food - 0.09% (3)
the search for - 0.09% (3)
key side-effects and - 0.09% (3)
scientific reporter for - 0.09% (3)
on formulation, dosing, - 0.09% (3)
union, with information - 0.09% (3)
in the european - 0.09% (3)
licensed for use - 0.09% (3)
and treatment as - 0.09% (3)
has just relaunched - 0.09% (3)
information on formulation, - 0.09% (3)
january 2017 a - 0.09% (3)
risk of pregnancy - 0.09% (3)
prep in the - 0.09% (3)
the uk have - 0.09% (3)
prevention of mother-to-child - 0.09% (3)
search for a - 0.09% (3)
dosing, key side-effects - 0.09% (3)
european union, with - 0.09% (3)
its series of - 0.09% (3)
use in the - 0.09% (3)
drugs licensed for - 0.09% (3)
more in our - 0.09% (3)
in our blog - 0.09% (3)
| 12 hours - 0.09% (3)
the european union, - 0.09% (3)
hiv factsheets, covering - 0.09% (3)
with information on - 0.09% (3)
hiv treatment and - 0.09% (3)
for use in - 0.09% (3)
what is hiv? - 0.09% (3)
access to hiv - 0.09% (3)
infectiousness and treatment - 0.09% (3)
transmission and prevention - 0.09% (3)
for a cure - 0.09% (3)
new and experimental - 0.09% (3)
some of the - 0.09% (3)
anti-hiv drugs licensed - 0.09% (3)
have an accurate - 0.09% (3)
official scientific reporter - 0.09% (3)
what is aids? - 0.09% (3)
doctor or another - 0.06% (2)
which pregnant and - 0.06% (2)
investigators report in - 0.06% (2)
treatment and its - 0.06% (2)
use for prevention - 0.06% (2)
| 13 january - 0.06% (2)
ago hiv and - 0.06% (2)
statement on access - 0.06% (2)
to hiv treatment - 0.06% (2)
say toronto star - 0.06% (2)
hours ago hiv - 0.06% (2)
and its use - 0.06% (2)
talk to your - 0.06% (2)
consensus statement is - 0.06% (2)
consensus statement on - 0.06% (2)
healthcare team for - 0.06% (2)
support, rather than - 0.06% (2)
replace, consultation with - 0.06% (2)
member of your - 0.06% (2)
antiretroviral therapy (art) - 0.06% (2)
a healthcare professional. - 0.06% (2)
is intended to - 0.06% (2)
bad science and - 0.06% (2)
to medicines and - 0.06% (2)
with a healthcare - 0.06% (2)
uk health services - 0.06% (2)
nam is the - 0.06% (2)
for the 25th - 0.06% (2)
conference (hr17) 09 - 0.06% (2)
people you have - 0.06% (2)
06 december 2016 - 0.06% (2)
world aids day - 0.06% (2)
25 november 2016 - 0.06% (2)
information is intended - 0.06% (2)
to support, rather - 0.06% (2)
than replace, consultation - 0.06% (2)
and linkage to - 0.06% (2)
experimental hiv treatments - 0.06% (2)
professional. talk to - 0.06% (2)
and medical ethics - 0.06% (2)
your doctor or - 0.06% (2)
neurological and cognitive - 0.06% (2)
benefits and housing - 0.06% (2)
and theoretical transmission - 0.06% (2)
with a low - 0.06% (2)
of hiv and - 0.06% (2)
another member of - 0.06% (2)
your healthcare team - 0.06% (2)
for advice tailored - 0.06% (2)
health services and - 0.06% (2)
to your situation. - 0.06% (2)
drug policy and - 0.06% (2)
interactions and pharmacokinetics - 0.06% (2)
aidsmap hiv & - 0.06% (2)
health.visit our factsheets - 0.06% (2)
women with hiv - 0.06% (2)
telling people you - 0.06% (2)
medicines and treatment - 0.06% (2)
global health initiatives - 0.06% (2)
delivery of care - 0.06% (2)
services and systems - 0.06% (2)
tuberculosis and hiv - 0.06% (2)
child developmental issues - 0.06% (2)
in children | - 0.06% (2)
hiv treatment in - 0.06% (2)
a families and - 0.06% (2)
and hiv hepatitis - 0.06% (2)
and the law - 0.06% (2)
consent and medical - 0.06% (2)
money, benefits and - 0.06% (2)
policy and policing - 0.06% (2)
and legal issues - 0.06% (2)
how hiv works - 0.06% (2)
treatment hiv treatment - 0.06% (2)
understanding of their - 0.06% (2)
injectables: prep in - 0.06% (2)
pregnancy loss among - 0.06% (2)
smokers much higher - 0.06% (2)
for women with - 0.06% (2)
an hiv test - 0.06% (2)
health monitoring hiv - 0.06% (2)
behaviour change interventions - 0.06% (2)
treatment for women - 0.06% (2)
outcomes and prognosis - 0.06% (2)
and bogus treatments - 0.06% (2)
medical procedures and - 0.06% (2)
other blood-borne exposure - 0.06% (2)
theoretical transmission risks - 0.06% (2)
linkage to care - 0.06% (2)
hiv causes disease - 0.06% (2)
much higher for - 0.06% (2)
pagefind out more - 0.06% (2)
the key aspects - 0.06% (2)
of a topic, - 0.06% (2)
providing easy-to-understand information - 0.06% (2)
for individuals who - 0.06% (2)
want to take - 0.06% (2)
care of their - 0.06% (2)
held in montréal, - 0.06% (2)
factsheet gives a - 0.06% (2)
drugs chart a - 0.06% (2)
pro vich website - 0.06% (2)
nam aidsmap hiv - 0.06% (2)
people taking art - 0.06% (2)
implants and injectables: - 0.06% (2)
loss among smokers - 0.06% (2)
brief overview of - 0.06% (2)
treatment and care.each - 0.06% (2)
well with a - 0.06% (2)
(hr17) 09 january - 0.06% (2)
low cd4 count - 0.06% (2)
guide to the - 0.06% (2)
just found out - 0.06% (2)
reference guide to - 0.06% (2)
for hiv services - 0.06% (2)
is the official - 0.06% (2)
(hr17) is being - 0.06% (2)
in hiv prevention, - 0.06% (2)
here – our - 0.06% (2)
factsheets on hiv - 0.06% (2)
prevention and treatment - 0.06% (2)
about hiv and - 0.06% (2)
hiv factsheets nam - 0.06% (2)
most important topics - 0.06% (2)
advice tailored to - 0.06% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.